Syneron Medical Ltd: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
68.71 Mil |
| Income |
-27.38 Mil |
| Net Profit Margin |
-40.00% |
| Return on Equity |
-11.31% |
| Debt/Equity Ratio |
0.00 |
|
| Revenue/Share |
2.50 |
| Earnings/Share |
-1.00 |
| Book Value/Share |
8.46 |
| Dividend Rate |
0.00 |
| Payout Ratio |
0.00% |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 11.9 | 34.1 | 32.3 |
| 2nd Qtr | 14.2 | 38.2 | 37.5 |
| 3rd Qtr | NA | 28.5 | 33.1 |
| 4th Qtr | NA | 14.2 | 38.1 |
| Total | 26.0 | 115.0 | 141.0 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -$0.30 | $0.30 | $0.31 |
| 2nd Qtr | -$0.20 | $0.40 | $0.37 |
| 3rd Qtr | NA | $0.08 | $0.29 |
| 4th Qtr | NA | -$0.58 | $0.16 |
| Total | -$0.50 | $0.20 | $1.13 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 48% | 88% | --- |
| 2nd Qtr | 33% | 33% | 19% |
| 3rd Qtr | NA | -80% | -22% |
| 4th Qtr | NA | NA | -45% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | NA | -3% |
| 2nd Qtr | NA | 8% |
| 3rd Qtr | NA | -72% |
| 4th Qtr | NA | NA |
advertisement
Recent News